glp-1 pediatric trials aim to expand weight loss drugs to younger children GLP-1 receptor agonists in pediatric

Frias JP, Bastyr EJ, Vignati L, Tschp MH, Schmitt C, Owen K, et al

public comment period closes June 29, 2026 - large-scale 503B compounding pathway under active regulatory review 503A patient-specific compounding: operates under a separate legal framework independent of shortage-list status

Consider a lower-cost provider, compounded alternatives , or discussing affordability options with your provider before turning to financing

Del Prato S, Kahn SE, Pavo I, et al

So the international-versus-US gap is widening, not closing, for American patients in the near term

Whether you are taking a GLP-1 receptor agonist or other medications or just getting started on your weight loss journey, eating more of the foods called out in this post is a great place to start